Wash. Rev. Code » Title 69 · Chapter 69.51
Revised Code of Washington

Wash. Rev. Code § 69.51.020 (2026)

Legislative purpose

✓ current as of May 2026
Find cases: SyfertCases citing this section WA-LEGapp.leg.wa.gov JustiaTitle on Justia CornellLII Search CasesGoogle Scholar
The legislature finds that recent research has shown that the use of cannabis may alleviate the nausea and ill effects of cancer chemotherapy and radiology, and, additionally, may alleviate the ill effects of glaucoma. The legislature further finds that there is a need for further research and experimentation regarding the use of cannabis under strictly controlled circumstances. It is for this purpose that the controlled substances therapeutic research act is hereby enacted.
[ 2022 c 16 s 112; 1979 c 136 s 2.]

Notes:

Intent—Finding—2022 c 16: See note following RCW 69.50.101.
Notes of Decisions
Cited in 2 cases, 1997–1997 · leading case: Seeley v. State, 940 P.2d 604 (Wash. 1997).
Sort: Relevance Newest Treatment
Seeley v. State, 940 P.2d 604 (Wash. 1997). “RCW 69.51.020; see also CP at 41. Although still law, the Legislature stopped funding the program in 1980.”
Seeley v. State, 940 P.2d 604 (Wash. 1997). “RCW 69.51.020; see also CP at 41. Although still law, the Legislature stopped funding the program in 1980.”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.